People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids, new treatment ...

The guidelines recommend that this occipital nerve block be combined with IV prochlorperazine, a drug that treats nausea and ...

SAN ANTONIO -- Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab and pertuzumab (Perjeta) ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Despite advances in transplant capacity and policy frameworks, early detection, affordable treatment, and coordinated ...

The Accepted Abstract Provides Supportive Evidence for the TAMP™ Therapy Platform’s Novel, Localized Approach to Targeted Chemotherapeutic Delivery via Additional Pharmacokinetic and Pharmacodynamic D ...

Jason Collins reveals he has stage 4 glioblastoma and details rapid symptoms and treatment plans as he fights one of the ...

A late-breaking presentation at the American Society of Hematology (ASH) 2025 meeting revealed promising phase 3 findings for ...

Based on phase 3 trial data, the FDA accepted an sBLA for nivolumab plus AVD for untreated stage III or IV classical Hodgkin lymphoma.

The subcutaneous administration of the established immunotherapy could free up an estimated 30,000 hours of infusion chair ...

This immunotherapy treatment holds promise beyond rectal cancer. In early studies of people with esophageal, bladder, or ...